Press Release

NeoGenomics Reports First Quarter 2023 Results

NeoGenomics to Participate at the BofA Securities 2023 Healthcare Conference

NeoGenomics to Announce First Quarter 2023 Financial Results

NeoGenomics to Participate at the 22nd Annual Needham Virtual Healthcare Conference

NeoGenomics to Share Nine Abstracts at the American Association of Cancer Research (AACR) Annual Meeting 2023

NeoGenomics to Host Investor Day on April 4, 2023

NeoGenomics Announces Commercial Availability of the RaDaR(R) Molecular Residual Disease Test

NeoGenomics Expands NGS Portfolio with Launch of Neo Comprehensive(TM) - Solid Tumor CGP and Neo Comprehensive(TM) - Myeloid Disorders CGP

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients